About Lyfscience Medtech Private Limited
Data last updated: 13 February 2026
Lyfscience Medtech Private Limited is a private limited company based in Mumbai, Maharashtra, India, recognised as a startup by DPIIT. It specialises in online healthcare services, a part of the broader internet and digital services sector. Incorporated on 16 March 2018, the company has been in operation for over 8 years.
Registered with ROC Mumbai under CIN U74999MH2018PTC306653.
Capital: an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1.04 Lakh. It is led by directors including Kamini Vinod Parmar and Tushar Patnaik.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: B – 604 Madhuvan Shimpoli Gorai Road Near Sbi Colony Borivali (West)., Mumbai, Maharashtra, India – 400092.
As per the financials filed for FY 2024, the company reported a revenue of ₹20.49 Lakh, a decline of 71% compared to the previous year.
The company is associated with 1 brand - Lyflink.
For more details, the company can be reached via its website lyflink.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media**************
-
Registered AddressB – 604 Madhuvan Shimpoli Gorai Road Near Sbi Colony Borivali (West)., Mumbai, Maharashtra, India – 400092
-
IndustryInternet, Online Healthcare Services
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Lyfscience Medtech Private Limited
Lyfscience Medtech Private Limited operates one associated brand: Lyflink. These brands represent Lyfscience Medtech Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Serves as a platform offering a suite of healthcare services for improved patient care. | lyflink.com |
Competitors & Alternatives of Lyfscience Medtech Private Limited
Brands and companies operating in the same space as Lyfscience Medtech Private Limited include MediBuddy, CureBay, Practo and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
MediBuddy
|
Online platform offering multiple healthcare services | Bengaluru, India, India | 2013 |
CureBay
|
Healthcare services are delivered via an online platform. | Bhubaneswar, India, India | 2020 |
Practo
|
Doctor appointments are booked and healthcare professionals are consulted online. | Bengaluru, India, India | 2008 |
CallHealth
|
Integrated at-home healthcare services, including tele-consultation and diagnostics, are provided. | Hyderabad, India, India | 2013 |
API Holdings
|
Digital healthcare tools are offered for pharmacies and clinics management. | Mumbai, India, India | 2012 |
Mfine
|
Provider of online doctor consultations, at-home lab tests, and health packages | Bengaluru, India, India | 2017 |
MedCords
|
Telepharmacy and teleconsultation services are delivered through a mobile app. | Kota, India, India | 2017 |
UCare
|
An online platform for employee healthcare management is provided. | Mumbai, India, India | 2018 |
Business Activity of Lyfscience Medtech Private Limited
Lyfscience Medtech Private Limited is engaged in the principal business activity of hospital and medical care, with detailed activities including hospital activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q1 | Hospital activities | ********* |
Auditor Details of Lyfscience Medtech Private Limited
Lyfscience Medtech Private Limited is audited by Mehta Chokshi & Shah LLP for the financial year 2022. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Mehta Chokshi & Shah LLP | blur-value | blur-value | blur-value |
Board of Directors of Lyfscience Medtech Private Limited
Lyfscience Medtech Private Limited is governed by 4 directors who oversee the company's operations and strategic decisions.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Kamini Vinod Parmar
Also directs:
Digited Solutions Llp, One World Healthcare Llp
|
Director | 16 Mar 2018 | 8 Years 3 Months | Current |
| Tushar Patnaik | Director | 31 Mar 2025 | 1 Years 3 Months | Current |
|
Sarthak Patnaik
Also directs:
Digited Solutions Llp, One World Healthcare Llp, Landmark Metals Private Limited and 4 more
|
Director | 16 Mar 2018 | 8 Years 3 Months | Current |
|
Sudeshna Patnaik
Also directs:
Digited Solutions Llp
|
Director | 10 Aug 2025 | 0 Years 10 Months | Current |
Financials of Lyfscience Medtech Private Limited FY 2025 filings available
Lyfscience Medtech Private Limited reported revenue of ₹20.49 Lakh (down 71% YoY) for FY 2024. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Lyfscience Medtech Private Limited
As of FY 2022, Lyfscience Medtech Private Limited's shareholding pattern shows 96.01% by promoters. The promoters hold a majority stake, indicating strong promoter control.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings Lyfscience Medtech Private Limited
Lyfscience Medtech Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Lyfscience Medtech Private Limited
View historical data on people associated with Lyfscience Medtech Private Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Lyfscience Medtech Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Lyfscience Medtech Private Limited
GSTIN & GST Filing Data of Lyfscience Medtech Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Lyfscience Medtech Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Lyfscience Medtech Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Lyfscience Medtech Private Limited
MSME Payment Delays by Lyfscience Medtech Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Lyfscience Medtech Private Limited
Subsidiaries & Group Companies of Lyfscience Medtech Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Lyfscience Medtech Private Limited with ownership details.
MCA Filings & Documents of Lyfscience Medtech Private Limited
MCA Filings & Documents of Lyfscience Medtech Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Lyfscience Medtech Private Limited
Frequently Asked Questions about Lyfscience Medtech Private Limited
Lyfscience Medtech Private Limited is an active private limited company in the internet sector based in Mumbai, Maharashtra, India. It was incorporated on 16 March 2018 (8+ years old) and is registered under CIN U74999MH2018PTC306653.
Lyfscience Medtech Private Limited reported revenue of ₹20.49 Lakh for FY 2024 (down 71.00% YoY).
The current directors of Lyfscience Medtech Private Limited are:
The primary industry of Lyfscience Medtech Private Limited is internet. The company specifically operates in online healthcare services. The company is currently active in this sector.
Yes, Lyfscience Medtech Private Limited is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Lyfscience Medtech Private Limited can be reached at the registered office: B – 604 Madhuvan Shimpoli Gorai Road Near Sbi Colony Borivali West, Mumbai, Maharashtra, India – 400092, or through the website lyflink.com.